Skip to content

Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers

Study on Artificial Intelligence-Based Facial and Speech-Related Patterns in Parkinson's Disease and Their Digital Biomarkers

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT07392411
Enrollment
720
Registered
2026-02-06
Start date
2023-07-25
Completion date
2026-12-31
Last updated
2026-02-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy Control, Multiple System Atrophy, Parkinson's Disease, Progressive Supranuclear Palsy(PSP)

Brief summary

This research employs AI to analyze facial expressions and speech patterns, aiming to develop new digital tools for diagnosing and differentiating Parkinson's disease and similar disorders.

Interventions

The patient's facial expressions and speech characteristics were recorded via video for assessment purposes.

Sponsors

Beijing Tiantan Hospital
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
15 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

1. Inclusion Criteria for Parkinson's Disease (PD) Group: (1) Diagnostic Criteria: Meet the diagnostic criteria for Parkinson's disease established by the Movement Disorder Society (MDS) in 2015. (2) Age Range: 18-75 years old. (3) Disease Severity: Early-stage PD: Hoehn-Yahr score ≤ 2.5 points. Mid-to-late-stage PD: Hoehn-Yahr score 2.5-5 points. (4) Consent for Data Collection: Willing to undergo facial expression video and speech audio recording. (5) Informed Consent: Signed informed consent form. 2. Inclusion Criteria for Parkinson's Plus Syndromes (MSA-P, PSP) Group: (1) Age Range: 18-75 years old. (2) Diagnostic Criteria: MSA patients must meet the diagnostic criteria established by the \[Chinese Expert Consensus on the Diagnosis of Multiple System Atrophy, 2017\]. PSP patients must meet the diagnostic criteria established by the \[Chinese Clinical Diagnostic Criteria for Progressive Supranuclear Palsy, 2016 Edition\]. (3) Consent for Data Collection: Willing to undergo facial expression video and speech audio recording. (4) Informed Consent: Signed informed consent form.

Exclusion criteria

1. History of cerebrovascular disease, head trauma, hydrocephalus, brain tumors, or intracranial surgery. 2. Presence of metal implants, cardiac pacemakers, or other metallic foreign bodies (applies to PD patients). 3. Severe dyskinesia in PD patients that would compromise cooperation with video/audio recording. 4. Mini-Mental State Examination (MMSE) score ≤ 24 points.

Design outcomes

Primary

MeasureTime frameDescription
Diagnostic Accuracy of the AI Model in Assessing [ Disease/Condition ] SeverityBaselineThe effectiveness of the model was demonstrated through a comparison between model-predicted scores and human expert ratings.

Countries

China

Contacts

CONTACTLingyan Ma, M.D.
Jennifer_MLY@163.com+8613520873987

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 7, 2026